137 related articles for article (PubMed ID: 6946291)
41. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
Crews KR; Liu T; Rodriguez-Galindo C; Tan M; Meyer WH; Panetta JC; Link MP; Daw NC
Cancer; 2004 Apr; 100(8):1724-33. PubMed ID: 15073863
[TBL] [Abstract][Full Text] [Related]
42. En bloc resections for osteogenic sarcoma.
Marcove RC; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):165-8. PubMed ID: 6946289
[TBL] [Abstract][Full Text] [Related]
43. Tissue necrosis after chemotherapy in osteosarcoma as the important prognostic factor.
Sami SH; Rafati AH; Hodjat P
Saudi Med J; 2008 Aug; 29(8):1124-9. PubMed ID: 18690304
[TBL] [Abstract][Full Text] [Related]
44. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
45. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
Meyers PA; Schwartz CL; Krailo M; Kleinerman ES; Betcher D; Bernstein ML; Conrad E; Ferguson W; Gebhardt M; Goorin AM; Harris MB; Healey J; Huvos A; Link M; Montebello J; Nadel H; Nieder M; Sato J; Siegal G; Weiner M; Wells R; Wold L; Womer R; Grier H
J Clin Oncol; 2005 Mar; 23(9):2004-11. PubMed ID: 15774791
[TBL] [Abstract][Full Text] [Related]
46. [The Zurich experience with preoperative high-dose methotrexate in osteosarcomas].
Honegger HP; Cserhati MD; von Hochstetter A; Hofmann V; Groscurth P
Schweiz Med Wochenschr; 1983 May; 113(18):663-71. PubMed ID: 6575441
[TBL] [Abstract][Full Text] [Related]
47. Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors.
Rosen G; Caparros B; Groshen S; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Huvos AG
Cancer Invest; 1984; 2(3):181-92. PubMed ID: 6203625
[TBL] [Abstract][Full Text] [Related]
48. Treatment of osteogenic sarcoma. II. Aggressive resection of pulmonary metastases.
Rosenburg SA; Flye MW; Conkle D; Seipp CA; Levine AS; Simon RM
Cancer Treat Rep; 1979 May; 63(5):753-6. PubMed ID: 287554
[TBL] [Abstract][Full Text] [Related]
49. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
Marroum MC; Huvos AG; Rosen G
Oncology; 1977; 34(6):273-80. PubMed ID: 304199
[TBL] [Abstract][Full Text] [Related]
50. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Winkler K; Beron G; Kotz R; Salzer-Kuntschik M; Beck J; Beck W; Brandeis W; Ebell W; Erttmann R; Göbel U; Havers W; Henze G; Hinderfield L; Höcker P; Jobke A; Jürgens H; Kabisch H; Landbeck G; Preusser P; Prindull G; Ramach W; Ritter J; Sekera J; Treuner J; Wüst G
J Cancer Res Clin Oncol; 1983; 106 Suppl():1-7. PubMed ID: 6193123
[TBL] [Abstract][Full Text] [Related]
52. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.
Rosen G; Marcove RC; Huvos AG; Caparros BI; Lane JM; Nirenberg A; Cacavio A; Groshen S
J Cancer Res Clin Oncol; 1983; 106 Suppl():55-67. PubMed ID: 6604058
[TBL] [Abstract][Full Text] [Related]
53. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
Allen JC; Rosen G
Ann Neurol; 1978 May; 3(5):441-4. PubMed ID: 310278
[TBL] [Abstract][Full Text] [Related]
54. Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma.
Mosende C; Gutierrez M; Caparros B; Rosen G
Cancer; 1977 Dec; 40(6):2779-86. PubMed ID: 73409
[TBL] [Abstract][Full Text] [Related]
55. Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma--experience in Korea cancer hospital.
Lee SY; Jeon DG; Kim SS; Jang JJ; Cho KJ
J Korean Med Sci; 1993 Apr; 8(2):121-6. PubMed ID: 8397928
[TBL] [Abstract][Full Text] [Related]
56. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Winkler K; Beron G; Kotz R; Salzer-Kuntschik M; Beck J; Beck W; Brandeis W; Ebell W; Erttmann R; Göbel U
J Clin Oncol; 1984 Jun; 2(6):617-24. PubMed ID: 6202851
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of chemotherapy dosage characteristics in children with osteogenic sarcoma.
Leung S; Marshall GM; al Mahr M; Tobias V; Lee DB; Hughes DO
Med Pediatr Oncol; 1997 Mar; 28(3):179-82. PubMed ID: 9024512
[TBL] [Abstract][Full Text] [Related]
58. Toxicity associated with combination chemotherapy for osteosarcoma: a report of the cooperative osteosarcoma study (COSS 80).
Jürgens H; Beron G; Winkler K
J Cancer Res Clin Oncol; 1983; 106 Suppl():14-8. PubMed ID: 6350313
[TBL] [Abstract][Full Text] [Related]
59. High-dose methotrexate and adriamycin in osteogenic sarcoma: the children's hospital of Philadelphia study.
Lange B; Kramer S; Gregg JR; Toledano S; Wimmer R; Evans AE
Am J Clin Oncol; 1982 Feb; 5(1):3-8. PubMed ID: 6979238
[TBL] [Abstract][Full Text] [Related]
60. Neoadjuvant chemotherapy for osteogenic sarcoma: a five year follow-up (T-10) and preliminary report of new studies (T-12).
Rosen G; Nirenberg A
Prog Clin Biol Res; 1985; 201():39-51. PubMed ID: 3867902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
